Featured

Insitute Director of Research Affairs publishes review piece

News Outlet: 
Nature Reviews Genetics
Date published: 
July 18, 2011
Download PDF: 
application/pdf iconnature_reviews_cgunter.pdf

The Cancer Genome Atlas completes detailed ovarian cancer analysis

HudsonAlpha Institute contributes to largest cancer genome study from NIH consortium
 Watch Video

HUNTSVILLE, Ala - Integrating 500 patient samples and multiple genomic technologies, The Cancer Genome Atlas Research Network has, according to a release by the National Institutes of Health, assembled the most comprehensive view of cancer genes for any cancer type to date.  The analyses of data are reported in the June 30 issue of Nature.

Hundreds attend 2011 Spring Benefit reception

Photo of Dr. Rick Myers speaking to guests at 2011 Spring Reception for Research on Psychiatric Disorders.

Thanks to everyone who attended the HudsonAlpha reception highlighting research on psychiatric disorders held on May 19. More than 250 guests were on hand for the event, which was held in lieu of the Spring Benefit for Research on Psychiatric Disorders. The original benefit was scheduled for April 28, but the event was canceled after tornadoes ripped through Alabama, impacting so many in our area.

The reception maintained the original focus of the benefit - psychiatric research underway at HudsonAlpha. Proceeds from the event will support current and future research into major depressive disorder, schizophrenia and bipolar disorder.

Categories:

A User's Guide to ENcyclopedia of DNA Elements

HudsonAlpha is part of international team releasing massive dataset
 
HUNTSVILLE, Ala. - The international team of the ENCODE, or Encyclopedia Of DNA Elements project, has created an overview of its ongoing large-scale efforts to interpret the human genome sequence. 
 

HudsonAlpha to use Sequencing to Uncover Genes Responsible for Adverse Drug Response in Parkinson's

News Outlet: 
GenomeWeb
Date published: 
March 8, 2011
Download PDF: 
application/pdf icongenomeweb_ha_parkinsons.pdf

By Monica Heger
GenomeWeb

In an example of how sequencing can be used to study not onlythe genetic underpinnings of disease but also the genetics of drug response, researchers at the HudsonAlpha Institute for Biotechnology have teamed up with clinicians at the University of Alabama, Birmingham, to perform transcriptome sequencing on 200 brain tissue samples, from patients and healthy individuals, as well as whole-exome sequencing on the genomes of 100 Parkinson's patients enrolled in a clinical trial for the drug levodopa.

Space Camp an adventure for Neuqua student

News Outlet: 
TribLocal Naperville
Date published: 
March 10, 2011
Download PDF: 
application/pdf iconnapierville_triblocal_honeywell.pdf

Experiencing the G-force of a space shuttle, extracting the DNA of a plant and acting as an impromptu translator aren’t things Veronica Picchi does in a normal week at Neuqua Valley High School.

Former Huntsville/Madison County Chamber CEO excited about new challenges in Birmingham area

News Outlet: 
The Huntsville Times
Date published: 
March 13, 2011
Download PDF: 
application/pdf iconhtimes_hilson.pdf

By Marian Accardi
The Huntsville Times

HUNTSVILLE, Ala. - When Brian Hilson interviewed for senior vice president for economic development with the Huntsville/Madison County Chamber of Commerce, he was happy working with a Birmingham development organization.

But, mostly out of curiosity, he decided to check out the job in Huntsville, his hometown, in the spring of 1992.

He was greeted at the breakfast meeting by a room full of community leaders, among them then-Mayor Steve Hettinger; Madison County Commission Chairman Mike Gillespie; Steve Monger, the chamber's chair-elect at the time; W.F. Sanders, the past chamber chair; and Joe Hinds, then chair of the Huntsville Industrial Development Board.

FDA Awards EGEN, Inc. Orphan -Drug Grant for Clinical Development of EGEN-001 for Treatment of Ovarian Cancer

News Outlet: 
PR Newswire
Date published: 
February 2, 2011
Download PDF: 
application/pdf iconprnewswire_egen.pdf

HUNTSVILLE, Ala., Feb. 2, 2011 /PRNewswire/ -- EGEN, Inc. today announced that the Food and Drug Administration (FDA) has awarded the company a four-year grant of $1,600,000 to assist in the Phase II clinical development of EGEN-001, the company's lead product. EGEN-001 is under clinical development for the treatment of advanced recurrent ovarian cancer.  EGEN has successfully completed two Phase I trials of EGEN-001 in ovarian cancer patients.

Biotech company iXpressGenes creating new DNA for research at Huntsville's HudsonAlpha Institute

News Outlet: 
The Huntsville Times
Date published: 
February 1, 2011
Download PDF: 
application/pdf iconhtimes_ixpressgenes.pdf

By Lee Roop
Photo credit: Eric Schultz, The Huntsville Times

Dr. Joe NgHUNTSVILLE, Ala. - A Huntsville startup company is using the emerging science of synthetic biology to create "biological Legos" scientists can use to modify living organisms. Dr. Joseph Ng's company, iXpressGenes, is making genes "from scratch" now in a laboratory at HudsonAlpha Institute for Biotechnology. "Scratch" is the key word, Ng said last week. "Instead of cutting and pasting existing genes, we are creating new ones," Ng said.

HudsonAlpha looks to 2011 as the year its biotech campus takes root

News Outlet: 
The Huntsville Times
Date published: 
January 4, 2011
Download PDF: 
application/pdf iconhtimes_2011_biotech_campus.pdf

Passengers flying into and out of Huntsville's International Airport last year couldn't miss the big, curving excavations in Cummings Research Park.

The giant connected loops were eye-catchers, but the real "wow" moment came with reconition that the design is one of the world's largest - if not the largest - models of the DNA double-helix.

The paved double-helix will the garden path backbone of a 150-acre biotechnology campus anchored by the HudsonAlpha Institute for Biotechnology, and this could be the year companies start calling the campus home.

Syndicate content